A novel paclitaxel-eluting dedicated bifurcation stent: A case report from the first human use Taxus Petal trial

Catheterization and Cardiovascular Interventions

Volumn 73, Issue 5, 2009, Pages 637-640

  Johnson, Thomas W ^a   Kay, I Patrick ^b   Ormiston, John A ^a,b  

^a AUCKLAND CITY HOSPITAL   (New Zealand)

^b Mercy Hospital   (New Zealand)

Author keywords

Drug delivery; Percutaneous coronary intervention; Stent

Indexed keywords

PACLITAXEL;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CASE REPORT; CLINICAL FEATURE; CORONARY ARTERY ANOMALY; CORONARY ARTERY DILATATION; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; CORONARY SINUS; CORONARY STENT; DRUG DELIVERY SYSTEM; DRUG ELUTING STENT; DYSPNEA; HUMAN; INTRAVASCULAR ULTRASOUND; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; PERCUTANEOUS CORONARY INTERVENTION; RIGHT CORONARY ARTERY; RIGHT CORONARY ARTERY BIFURCATION; ST SEGMENT DEPRESSION;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CARDIOVASCULAR AGENTS; CLINICAL TRIALS AS TOPIC; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; DRUG-ELUTING STENTS; HUMANS; MALE; MIDDLE AGED; PACLITAXEL; PROSTHESIS DESIGN; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 65549099335     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.21943     Document Type: Article

References (13)

1. Colombo A, Moses J, Morice MC, Ludwig J, Holmes DR, Spanos V, Louvard Y, Desmedt B, Di Mario C, Leon MB. The randomized study to evaluate sirolimus-eluting stents implanted in coronary bifurcation lesions. Circulation 2004;109:1244-1249.
2. Ormiston JA. BSC Taxus Petal Stent: Updates from the First Human Use Study. Presented at the Transcatheter Therapeutics Meeting, Washington DC, Oct. 2008. Available at: http://www.tctmd.com/Show.aspx?id571164. Accessed: Oct 30, 2008.
3. Ormiston JA. Advanced 3D bench imaging to evaluate treatment approaches for bifurcation and lesions: Focus on dedicated bifurcation stents. Presented at the Transcatheter Therapeutics Meeting, Washington DC, Oct. 2008. Available at: http://www.tctmd.com/Show.aspx?id571138. Accessed: October 30, 2008.
4. Steigen TK, Maeng M, Wiseth R, Erglis A, Kumsars I, Narbute I, Gunnes P, Mannsverk J, Meyerdierks O, Rotevatn S, Niemelä M, Kervinen K, Jensen JS, Galløe A, Nikus K, Vikman S, Ravkilde J, James S, Aarøe J, Ylitalo A, Helqvist S, Sjögren I, Thayssen P, Virtanen K, Puhakka M, Airaksinen J, Lassen JF, Thuesen L. Randomized study of simple versus complex stenting of coronary artery bifurcation lesions. The Nordic Bifurcation Study. Circulation 2006;114:1955-1961.
5. Smith DH. BBC ONE. Presented at the Transcatheter Therapeutics Meeting, Washington DC, Oct. 2008. Available at: www.tctmd.com/ show.aspx?id574560. Accessed: October 30, 2008.
6. Ormiston JA, Webster MWI, El Jack S, Ruygrok PN, Stewart JT, Scott D, Currie E, Panther MJ, Shaw B, O'Shaughnessy B. Drug-eluting stents for coronary bifurcations: Bench-testing of provisional side-branch strategies. Cathet Cardiovasc Interv 2006;67:49-55.
7. Ormiston JA, Webster MWI, Ruygrok PN, Stewart JT, White HD, Scott DS. Stent deformation following simulated side branch dilatation: A comparison of five stent designs. Cathet Cardiovasc Interv 1999;47:258-264.
8. Ormiston JA, Webster MWI, Webber B, Stewart JT, Ruygrok PN, Hatrick RI. The "Crush." Technique for coronary artery bifurcation stenting: Insights from micro-computed tomographic imaging of bench deployments. J Am Coll Cardiol Interv 2008;1:351-357.
9. Costa RA, Mintz GS, Carlier SG, Lansky AJ, Moussa I, Fujii K, Takebayashi H, Yasuda T, Costa JR Jr, Tsuchiya Y, Jensen LO, Cristea E, Mehran R, Dangas GD, Iyer S, Collins M, Kreps EM, Colombo A, Stone GW, Leon MB, Moses JW. Bifurcation coronary lesions treated with the "crush" technique. An intravascular ultrasound analysis. J Am Coll Cardiol 2005;46:599-605.
10. Wentzel JJ, Krams R, Schuurbiers JC, Oomen JA, Kloet J, van der Giessen WJ, Serruys PW, Slager CJ. Relationship between neointimal thickness and shear stress after Wallstent implantation in human coronary arteries. Circulation 2001;103:1740-1745.
11. Stone GW, Ellis SG, Cox DA, Hermiller J, O'Shaughnessy CD, Tift Mann J, Turco M, Caputo R, Bergin P, Greenberg JD, Popma JJ, Russell ME. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. New Engl J Med 2004;350:221-231.
12. Stone GW, Ellis SG, Cannon L, Tift Mann J, Greenberg JD, Spriggs D, O'Shaughnessy CD, De Maio S, Hall P, Popma JJ, Koglin J, Russell ME. Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease. JAMA 2005;294:1215-1223.
13. Turco MA, Ormiston JA, Popma JJ, Mandinov L, O'shaughnessy CD, Tift Mann J, McGarry TF, Wu CJ, Chan C, Webster MWI, Hall JJ, Mishkel GJ, Cannon LA, Baim DS. Polymerbased, paclitaxel-eluting TAXUS liberte stent in de novo lesions: The pivotal TAXUS ATLAS trial. J Am Coll Cardiol 2007;49:1676-1683.